What’s Your Guidance for People Taking Avandia? (US News & World Report)

Some perspective on the diabetes drug, as the FDA prepares to consider its heart risks

GlaxoSmithKline responds to Staff Report on GlaxoSmithKline and the Diabetes Drug Avandia (News-Medical-Net)

Today, GlaxoSmithKline responded to the recently released Senate Committee on Finance's January 2010 "Staff Report on GlaxoSmithKline and the Diabetes Drug Avandia" (the "Staff Report").

Senators challenge safety of GlaxoSmithKlein's Avandia (CNN Money)

The diabetes drug Avandia is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, a Senate committee report released Saturday says.

Don't Ignore This Potential Blockbuster (The Motley Fool)

Five trials later, Roche's taspoglutide seems like a winner.

Avandia Information and Support Center Announces Launch of Avandia-Injury-Lawyer.com (PRWeb via Yahoo! News)

The Avandia Information and Support Center is proudly announcing the launch of Avandia-Injury-Lawyer.com, a brand new website whose aim is to provide vital information regarding the type-2 diabetes prescription drug Avandia.

New Scientific Studies Show Further Evidence of Avandia Dangers (PRWeb)

Two independent studies document serious medical risks associated with use of popular GlaxoSmithKline diabetes drug (PRWeb Feb 4, 2010) Read the full story at http://www.prweb.com/releases/2010/02/prweb3563424.htm

Research could help in developing more specific treatments for Type 2 diabetes (News-Medical-Net)

New research on Type 2 diabetes by Trinity College Dublin researchers could benefit young adults (aged 18-25 years) with the condition. The research led by Professor John Nolan of Trinity College Dublin and St James's Hospital, Dublin, has just been published online in the leading international journal, Diabetes Care.